AVTE Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Aerovate Therapeutics Inc - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 20.29 USD -2.22%

Updated:

Section:

Wall Street
Price Targets

Wall Street analysts forecast AVTE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AVTE is 45.56 USD with a low forecast of 27.27 USD and a high forecast of 68.25 USD.

AVTE Lowest Forecast

Wall Street Target

AVTE Average Forecast

Wall Street Target

AVTE Highest Forecast

Wall Street Target

34% Upside

125% Upside

236% Upside

The latest public price target was made on Apr 1, 2024 by Tiago Fauth from Wells Fargo , who expects AVTE stock to rise by 72% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst	Price Target	Date	Article
Tiago Fauth Wells Fargo	35 USD Upside 72%	1 month ago Apr 1, 2024	Wells Fargo Adds Aerovate Therapeutics Inc (AVTE) to Q2 '24 Tactical Ideas List StreetInsider
Eun Yang Jefferies	65 USD Upside 220%	1 month ago Mar 25, 2024	Aerovate Therapeutics Inc (AVTE) PT Raised to $65 at Jefferies, 'valuation does not suggest data needs to be better than sotatercept' StreetInsider

Price Target	35 USD
Upside/Downside	72%

Price Target	65 USD
Upside/Downside	220%

BioNTech SE

30% Upside

Abbisko Cayman Ltd

150% Upside

Ionis Pharmaceuticals Inc

35% Upside

Arrowhead Pharmaceuticals Inc

131% Upside

BioNTech SE

30% Upside

Abbisko Cayman Ltd

150% Upside

Ionis Pharmaceuticals Inc

35% Upside

Arrowhead Pharmaceuticals Inc

131% Upside

Acumen Pharmaceuticals Inc

274% Upside

Affimed NV

323% Upside

Invivyd Inc

295% Upside

Incyte Corp

41% Upside

Revenue
Forecast

N/A

N/A

N/A

N/A

What are analyst estimates?

Operating Income
Forecast

N/A

N/A

0%

What are analyst estimates?

Net Income
Forecast

N/A

N/A

-13%

What are analyst estimates?

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

According to Wall Street analysts, the average 1-year price target for AVTE is 45.56 USD with a low forecast of 27.27 USD and a high forecast of 68.25 USD.

Join more than 134,300+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.